Brief: BB Biotech FY 2019 Net Gain Of CHF 677 Mln

Bb Biotech

17/01/2020 06:09

Jan 17 (Reuters) - BB BIOTECH AG  BION.S :
    * BB BIOTECH BENEFITS FROM M&A TRANSACTIONS - DIVIDEND OF
CHF 3.40
PROPOSED
    * CONSOLIDATED, BUT NOT YET AUDITED Q4 2019 DATA FOR BB
BIOTECH
INDICATES A NET GAIN OF CHF 505 MN VERSUS 2018 Q4 LOSS OF CHF
643 MN
    * CONSOLIDATED, BUT NOT YET AUDITED FULL YEAR 2019 DATA
SHOWED A
NET GAIN OF CHF 677 MN COMPARED TO A NET LOSS OF CHF 471 MN FOR
2018
    * OUTLOOK FOR 2020 - SECTOR FUNDAMENTALS ARE EXCITING,
TRANSACTION
MOMENTUM IS EXPECTED TO CONTINUE

Source text for Eikon:  ID:nEQ5HXBVqa 
Further company coverage:  BION.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))